Among the recognized cytokines that play crucial roles in anti-tumor immunity are IFN-gamma (IFNG) and type I IFN [34], enhancing infiltrating CD8 + T cell-produced IFN-γ can boost tumor immunity, which in turn can trigger tumor retreat, by recruiting inflammatory cells to the tumor microenvironment. The gene discussed is IFNG; the disease is neoplasm.